Cart
0
Get 20% Free Customization In This Report
Buy this report from - $4176

Transdermal Drug Delivery Systems Market by Type of Delivery System [Passive (Matrix System and Reservoir System), Active [Structure Based, Electrical Based, (Iontophoresis, Electroporation, and Sonophoresis), and Others] and Application (Analgesics, Hormone Replacement Therapy, Cardiovascular Disorders, Motion Sickness, and Smoking Cessation) - Global Opportunity Analysis and Industry Forecast, 2017-2023

LI_17485
Pages: 150
Jun 2017 | 2486 Views
face gplus_n
Author's : Prateeksha Kaul & Garima Chandra
Tables: 55
Charts: 28
twit_n pr_n

Transdermal Drug Delivery Systems Market Overview:

Global Transdermal Drug Delivery Systems Market was valued at $32,516 million in 2016, and is estimated to reach $61,689 million by 2023, growing at a CAGR of 9.5% during the study period. Transdermal drug delivery systems are an alternative to oral intravascular, subcutaneous, and transmucosal routes, wherein the drugs are delivered through the skin for therapeutic use. Rise in geriatric population and upsurge in number of patients suffering from chronic disorders are expected to drive the market growth. Moreover, increase in adoption of third-generation transdermal drug delivery systems, such as iontophoresis, boosts the market growth. However, disadvantages of these delivery systems, such as irritation at the site of application and edema, are expected to impede the market growth.

Rise in Incidence of Chronic Disorders and Geriatric Population

As per the estimates of the World Health Organization, globally, more than 422 million people were diagnosed with diabetes in 2014. In addition, rise in geriatric population poses risk for increase in incidence of diabetes. For instance, aged people (>65 years of age) are more susceptible to Type 2 diabetes.

Growth in Asia-Pacific Region

Asia-Pacific offers lucrative opportunities for the market growth, owing to presence of large pool of patients suffering from chronic disorders, such as hypertension. According to a CADI Research Foundation, hypertension is the most prevalent disease in India. It is evident from the fact that the number of people with hypertension is projected to increase to 214 million in 2025 from 118 million in 2000. Hence, high incidence of cardiovascular disorders, such as hypertension, makes it an attractive market for transdermal drug delivery systems.

Recent Advancements

The market has witnessed development of new adhesives, molecular absorption enhancers, and penetration enhancers that are expected to enhance skin permeability, resulting in expansion of the range of drugs that are expected to be delivered through transdermal route. For instance, new technology, such as micro needle-enhanced delivery, helps easy transportation of drug across the skin without the sensation of pain.

Global Transdermal Drug Delivery Systems: Market Segmentation

GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS: MARKET SEGMENTATION

Get more information on this report : Request Sample Pages

The global transdermal drug delivery systems market is segmented on the basis of type of delivery system, application, and region. Based on type of delivery system, it is classified into passive and active delivery systems. The passive delivery systems are further divided into matrix system and reservoir system. Active delivery systems are categorized into structure based, electrical based, and others. By application, it is divided into analgesics, hormone replacement therapy, cardiovascular disorders, motion sickness, smoking cessation, and others. It is analyzed across regions, such as North America, Europe, Asia-Pacific, and LAMEA.

The key companies operating in the market include Novartis AG, Johnson & Johnson, Mylan N.V., Boehringer Ingelheim GmbH, Bayer AG, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Acrux Limited, Echo Therapeutics, Inc., and Endo Pharmaceuticals Inc.

South Africa: Transdermal Drug Delivery Systems Market, 2016-2023 ($Million)

South Africa: Transdermal Drug Delivery Systems Market, 2016-2023 ($Million)

Get more information on this report : Request Sample Pages

Key Benefits

  • The study provides an in-depth analysis of the global transdermal drug delivery systems market, with current trends and future estimations, to elucidate the imminent investment pockets.
  • Quantitative analysis from 2016 to 2023 is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Extensive analysis is conducted by closely following key product positioning and monitoring the top contenders within the market framework.

Transdermal Drug Delivery Systems Market Key Segments:

By Type of Delivery System

  • Passive
    • Matrix System
    • Reservoir System
  • Active
    • Structure Based
    • Electrical Based
      • Iontophoresis
      • Electroporation
      • Sonophoresis
    • Others

By Application

  • Analgesics
  • Hormone Replacement Therapy
  • Cardiovascular Disorders
  • Motion Sickness
  • Smoking Cessation
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.1. KEY BENEFITS
1.2. KEY MARKET SEGMENTS
1.3. RESEARCH METHODOLOGY

1.3.1. Secondary research
1.3.2. Primary research
1.3.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.2.2.1. Competitive intelligence of companies and their strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Rising geriatric population
3.4.1.2. Increasing prevalence of chronic disorders
3.4.1.3. Rise in adoption of third-generation delivery systems

3.4.2. Restraints

3.4.2.1. Side-effects of the systems

3.4.3. Opportunities

3.4.3.1. Emerging nations

Chapter: 4 TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY TYPE OF DELIVERY SYSTEM

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. PASSIVE DELIVERY SYSTEM

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.2.3.1. Matrix delivery system

4.2.3.1.1. Market size and forecast

4.2.3.2. Reservoir delivery system

4.2.3.2.1. Market size and forecast

4.3. ACTIVE DELIVERY SYSTEM

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.3.3.1. Structure-based drug delivery system

4.3.3.1.1. Market size and forecast

4.3.3.2. Electrically-based drug delivery system

4.3.3.2.1. Market size and forecast
4.3.3.2.2. Iontophoresis

4.3.3.2.2.1. Market size and forecast

4.3.3.2.3. Electroporation

4.3.3.2.3.1. Market size and forecast

4.3.3.2.4. Sonophoresis

4.3.3.2.4.1. Market size and forecast

4.3.3.3. Other

4.3.3.3.1. Market size and forecast

Chapter: 5 TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. ANALGESICS

5.2.1. Market size and forecast

5.3. HORMONE REPLACEMENT THERAPY

5.3.1. Market size and forecast

5.4. HYPERTENSION

5.4.1. Market size and forecast

5.5. MOTION SICKNESS

5.5.1. Market size and forecast

5.6. SMOKING CESSATION

5.6.1. Market size and forecast

5.7. OTHERS

5.7.1. Market size and forecast

Chapter: 6 TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY REGION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Growth factors and opportunities
6.2.3. Market size and forecast

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Growth factors and opportunities
6.3.3. Market size and forecast

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Growth factors and opportunities
6.4.3. Market size and forecast

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Growth factors and opportunities
6.5.3. Market size and forecast

Chapter: 7 COMPANY PROFILES

7.1. ACRUX LIMITED

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Business performance
7.1.5. Key strategic moves and developments
7.1.6. Strategy share (%)

7.2. BAYER AG

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Business performance
7.2.5. Key strategic moves and developments
7.2.6. Strategy share (%)

7.3. BOEHRINGER INGELHEIM GMBH

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Business performance
7.3.5. Key strategic moves and developments
7.3.6. Strategy share (%)

7.4. BRISTOL-MYERS SQUIBB COMPANY

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Business performance
7.4.5. Key strategic moves and developments
7.4.6. Strategy share (%)

7.5. ECHO THERAPEUTICS, INC.

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Business performance
7.5.5. Key strategic moves and developments
7.5.6. Strategy share (%)

7.6. ENDO PHARMACEUTICALS INC.

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Business performance
7.6.5. Key strategic moves and developments
7.6.6. Strategy share (%)

7.7. GLAXOSMITHKLINE PLC

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Business performance
7.7.5. Key strategic moves and developments
7.7.6. Strategy share (%)

7.8. JOHNSON & JOHNSON

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Business performance
7.8.5. Key strategic moves and developments
7.8.6. Strategy share (%)

7.9. MYLAN N.V.

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Business performance
7.9.5. Key strategic moves and developments
7.9.6. Strategy share (%)

7.10. NOVARTIS AG

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Business performance
7.10.5. Key strategic moves and developments
7.10.6. Strategy share (%)

LIST OF TABLES

TABLE 1. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY TYPE OF DELIVERY SYSTEM, 2016-2023 ($MILLION)
TABLE 2. GLOBAL PASSIVE DELIVERY SYSTEM MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 3. PASSIVE DELIVERY SYSTEM MARKET, BY REGION 2016-2023 ($MILLION)
TABLE 4. NORTH AMERICA PASSIVE DELIVERY SYSTEM MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 5. EUROPE PASSIVE DELIVERY SYSTEM MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 6. ASIA-PACIFIC PASSIVE DELIVERY SYSTEM MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 7. LAMEA PASSIVE DELIVERY SYSTEM MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 8. GLOBAL ACTIVE DELIVERY SYSTEM MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 9. ACTIVE DELIVERY SYSTEM MARKET, BY REGION 2016-2023 ($MILLION)
TABLE 10. NORTH AMERICA ACTIVE DELIVERY SYSTEM MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 11. EUROPE ACTIVE DELIVERY SYSTEM MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 12. ASIA-PACIFIC ACTIVE DELIVERY SYSTEM MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 13. LAMEA ACTIVE DELIVERY SYSTEM MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 14. GLOBAL ELECTRICALLY-BASED DRUG DELIVERY SYSTEM MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 15. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 16. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET FOR ANALGESICS, BY REGION, 2016-2023 ($MILLION)
TABLE 17. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET FOR HORMONE REPLACEMENT THERAPY, BY REGION, 2016-2023 ($MILLION)
TABLE 18. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET FOR ISCHEMIC STROKE, BY REGION, 2016-2023 ($MILLION)
TABLE 19. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET FOR MOTION SICKNESS, BY REGION, 2016-2023 ($MILLION)
TABLE 20. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET FOR SMOKING CESSATION, BY REGION, 2016-2023 ($MILLION)
TABLE 21. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET FOR OTHERS, BY REGION, 2016-2023 ($MILLION)
TABLE 22. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 23. NORTH AMERICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 24. NORTH AMERICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 25. NORTH AMERICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 27. EUROPE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 28. EUROPE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 29. EUROPE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY DISEASE PATHOLOGY, 2016-2023 ($MILLION)
TABLE 30. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 31. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 32. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY DISEASE PATHOLOGY, 2016-2023 ($MILLION)
TABLE 33. LAMEA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 34. LAMEA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 35. LAMEA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY DISEASE PATHOLOGY, 2016-2023 ($MILLION)
TABLE 36. ACRUX: COMPANY SNAPSHOT
TABLE 37. ACRUX: OPERATING SEGMENTS
TABLE 38. BAYER: COMPANY SNAPSHOT
TABLE 39. BAYER: OPERATING SEGMENTS
TABLE 40. BOEHRINGER: COMPANY SNAPSHOT
TABLE 41. BOEHRINGER: OPERATING SEGMENTS
TABLE 42. BRISTOL-MYERS SQUIBB: COMPANY SNAPSHOT
TABLE 43. BRISTOL-MYERS SQUIBB: OPERATING SEGMENTS
TABLE 44. ECHO: COMPANY SNAPSHOT
TABLE 45. ECHO: OPERATING SEGMENTS
TABLE 46. ENDO: COMPANY SNAPSHOT
TABLE 47. ENDO: OPERATING SEGMENTS
TABLE 48. GSK: COMPANY SNAPSHOT
TABLE 49. GSK: OPERATING SEGMENTS
TABLE 50. J&J: COMPANY SNAPSHOT
TABLE 51. J&J: OPERATING SEGMENTS
TABLE 52. MYLAN: COMPANY SNAPSHOT
TABLE 53. MYLAN: OPERATING SEGMENTS
TABLE 54. NOVARTIS: COMPANY SNAPSHOT
TABLE 55. NOVARTIS: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 1. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, 2016-2023
FIGURE 2. SEGMENTATION OF GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET
FIGURE 3. TOP INVESTMENT POCKETS IN GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET
FIGURE 4. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2016)
FIGURE 5. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 6. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 7. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 8. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 9. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 10. MARKET SHARE ANALYSIS, 2016
FIGURE 11. IMPACT ANALYSIS, TRANSDERMAL DRUG DELIVERY SYSTEM MARKET
FIGURE 12. GLOBAL MATRIX DELIVERY SYSTEM MARKET, 2016-2023 ($MILLION)
FIGURE 13. GLOBAL RESERVOIR DELIVERY SYSTEM MARKET, BY TYPE, 2016-2023 ($MILLION)
FIGURE 14. GLOBAL STRUCTURE-BASED DRUG DELIVERY SYSTEM MARKET, 2016-2023 ($MILLION)
FIGURE 15. GLOBAL IONTOPHORESIS DRUG DELIVERY SYSTEM MARKET, 2016-2023 ($MILLION)
FIGURE 16. GLOBAL ELECTROPORATION DRUG DELIVERY SYSTEM MARKET, 2016-2023 ($MILLION)
FIGURE 17. GLOBAL SONOPHORESIS DRUG DELIVERY SYSTEM MARKET, 2016-2023 ($MILLION)
FIGURE 18. GLOBAL OTHER DRUG DELIVERY SYSTEM MARKET, 2016-2023 ($MILLION)
FIGURE 19. ACRUX: FINANCIALS
FIGURE 20. BAYER: FINANCIALS
FIGURE 21. BOEHRINGER: FINANCIALS
FIGURE 22. BRISTOL-MYERS SQUIBB: FINANCIALS
FIGURE 23. ECHO: FINANCIALS
FIGURE 24. ENDO: FINANCIALS
FIGURE 25. GSK: FINANCIALS
FIGURE 26. J&J: FINANCIALS
FIGURE 27. MYLAN: FINANCIALS
FIGURE 28. NOVARTIS: FINANCIALS

 

Globally, chronic disorders, such as skin, cardiovascular, respiratory, and neurovascular, are the major health concern and economic burden on the society. Hence, the adoption of transdermal drug delivery systems is vital for effective treatment of these disorders.

Upsurge in the incidence of disorders, such as Parkinson’s disease, and increase in geriatric population have led to high adoption of transdermal drug delivery systems. In addition, introduction of innovative treatment techniques, such as third-generation transdermal drug delivery systems (microneedles), has further led to the market growth.

Asia-Pacific offers lucrative opportunities for the market growth due to increase in healthcare expenditure, rapid increase in geriatric population, and rise in incidence of chronic diseases. Thus, emerging countries, such as China and India, possess high growth potential for this market.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry

Request sample

OR

Purchase Full Report of
Transdermal Drug Delivery Systems Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Online Only
  • $4176
  • Online cloud Access only
  • Restected Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4640
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5540
  • Restricted to one authorized users
  • One print only
  • Available in PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6654
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprice
    License/PDF

  • $9280
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in PDF
  • 20% free customization (Pre-Sale)
  • Free quartery industry update
  • Free report update (Within 180 days)
  • Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo